BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37155846)

  • 21. Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.
    Wasil LR; Shair KHY
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.
    Guo L; Tang M; Yang L; Xiao L; Bode AM; Li L; Dong Z; Cao Y
    Int J Mol Med; 2012 Apr; 29(4):574-80. PubMed ID: 22266808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells.
    Yu H; Lu J; Zuo L; Yan Q; Yu Z; Li X; Huang J; Zhao L; Tang H; Luo Z; Liao Q; Zeng Z; Zhang J; Li G
    J Virol; 2012 Mar; 86(6):3088-99. PubMed ID: 22205737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma.
    Li B; Huang G; Zhang X; Li R; Wang J; Dong Z; He Z
    BMC Cancer; 2013 Mar; 13():124. PubMed ID: 23496845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the
    Shi F; Zhou M; Shang L; Du Q; Li Y; Xie L; Liu X; Tang M; Luo X; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Bode AM; Cao Y
    Theranostics; 2019; 9(9):2424-2438. PubMed ID: 31131045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
    Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
    Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
    PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
    Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.
    Port RJ; Pinheiro-Maia S; Hu C; Arrand JR; Wei W; Young LS; Dawson CW
    J Pathol; 2013 Nov; 231(3):367-77. PubMed ID: 23934731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
    Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
    Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
    Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
    Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.
    Caves EA; Butch RM; Cook SA; Wasil LR; Chen C; Di YP; Lee N; Shair KHY
    mSphere; 2017; 2(6):. PubMed ID: 29134204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
    Garcia P; Harrod A; Jha S; Jenkins J; Barnhill A; Lee H; Thompson M; Williams JP; Barefield J; Mckinnon A; Suarez P; Shah A; Lowrey AJ; Bentz GL
    Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
    Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
    Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
    Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
    PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.